Phibro Animal Health (PAHC) Capital Expenditures Growth (1y) (2014 - 2026)
Phibro Animal Health (PAHC) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 97.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -431.11% |
| Dec 31, 2025 | 217.03% |
| Sep 30, 2025 | -98.90% |
| Jun 30, 2025 | 0.54% |
| Mar 31, 2025 | -20.40% |
| Dec 31, 2024 | -57.13% |
| Sep 30, 2024 | 4,917.28% |
| Jun 30, 2024 | 20.03% |
| Mar 31, 2024 | -76.80% |
| Dec 31, 2023 | 175.35% |
| Sep 30, 2023 | -99.18% |
| Jun 30, 2023 | 149.06% |
| Mar 31, 2023 | 318.75% |
| Dec 31, 2022 | -414.84% |
| Sep 30, 2022 | 211.13% |
| Jun 30, 2022 | -9.21% |
| Mar 31, 2022 | -55.14% |
| Dec 31, 2021 | 2,646.36% |
| Sep 30, 2021 | 3,533.66% |
| Jun 30, 2021 | -162.21% |